Lipella Pharmaceuticals Inc. Shareholders' Equity
Lipella Pharmaceuticals Inc. (LIPO) had Shareholders' Equity of $1.49 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-14
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.49M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $2.74M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $4.08M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $1.92M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | $1.49M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.74M 10-Q · filed 2025-11-14 | |
| 2025-03-31 | $4.08M 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $1.92M 10-Q · filed 2025-11-14 | |
| 2024-09-30 | $1.46M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.70M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $2.56M 10-Q · filed 2025-11-14 | $2.56M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.14M 10-Q · filed 2025-11-14 | |
| 2023-09-30 | $2.22M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $3.13M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $3.82M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $4.68M 10-K · filed 2025-03-28 | |
| 2022-09-30 | -$62.82K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $352.21K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $920.75K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $1.42M 10-K · filed 2024-02-27 | |
| 2020-12-31 | $463.32K 10-K · filed 2023-03-31 |